COMBIVIR, a combination of 2 nucleoside analogue reverse transcriptase inhibitors, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.
Line by line instructions for how to complete the Expedited Adverse Events reporting form.
Lists of IND and non-IND protocols having case report forms (CRFs) and pharmacy records that will not be stored by DAIDS .
Quick reference card for creating a new submission in the DPRS.
CRF master inventory list template.
Term definitions and access rights for Reporters and Submitters using DAERS.
Technical guide to the DAERS system for Site Enrollment users.
Detailed manual on the DAERS system for Site Reporters and Study Physicians.
Formatted specifically for printing. applicable, to special instructions to keep in mind while entering values.
Who are DAIDS collaborators? How are they involved in the protocol development lifecycle? And other information about collaborators.
Guidance regarding the DAIDS deregistration process.
Process for collection of financial disclosure by clinical investigators conducting DAIDS-sponsored IND trials.
Guidance for implementing protocol clarifications or changes.
DAIDS investigator of record form (7/2020).